Different therapies of Chinese herbal medicine for diarrhea-predominant irritable bowel syndrome: A network meta-analysis of double-blinded, placebo-controlled …

N Liu, J Li, Y Wang, S Zhang - Journal of Ethnopharmacology, 2023 - Elsevier
Abstract Ethnopharmacological relevance: Shuganjianpi Therapy (SGJP), Jianpi Therapy
(JP), Shugan Therapy (SG), Jianpiwenshen Therapy (JPWS), and Shuganjianpiwenshen …

Efficacy of Chinese herbal medicine for diarrhea‐predominant irritable bowel syndrome: a meta‐analysis of randomized, double‐blind, placebo‐controlled trials

JJ Zhu, S Liu, XL Su, ZS Wang, Y Guo… - Evidence‐Based …, 2016 - Wiley Online Library
Objective. To explore the efficacy of Chinese herbal medicine in treating diarrhea‐
predominant irritable bowel syndrome (D‐IBS). Methods. Four English and four Chinese …

[HTML][HTML] Pharmacological treatments of Chinese herbal medicine for irritable bowel syndrome in adults: A network meta-analysis of randomized controlled trials

Y Wu, Y Dai, L Zhang, H Pan, W Chen, R Li, L Hu - Plos one, 2021 - journals.plos.org
Introduction Plenty of clinical studies have suggested the value of Chinese herbal medicine
(CHM) for patients with irritable bowel syndrome (IBS), but their efficacy and safety have not …

[HTML][HTML] Gwakhyangjeonggi-san for irritable bowel syndrome: a protocol for systematic review and meta-analysis

J Park, SJ Ko, G Han, K Kim, H Jun, JW Park - Medicine, 2021 - journals.lww.com
Background: Irritable bowel syndrome (IBS) is a chronic functional bowel disorder
characterized by abdominal pain or discomfort, stool irregularities, and bloating. Owing to its …

[HTML][HTML] The Chinese herbal formula Huoxiang Zhengqi for diarrhea-predominant irritable bowel syndrome (CHAIRS): a study protocol for a double-blinded …

X Guo, M Xuan, H Zheng, S Qin, H Wu, S Huang… - Trials, 2021 - Springer
Background Diarrhea-predominant irritable bowel syndrome (IBS-D) is a common chronic
digestive disease. Recent observational studies have reported that the Chinese herbal …

[HTML][HTML] Chinese herbal medicine for irritable bowel syndrome: a meta-analysis and trial sequential analysis of randomized controlled trials

H Zheng, S Jin, YL Shen, WY Peng, K Ye… - Frontiers in …, 2021 - frontiersin.org
Purpose: Chinese herbal medicine (CHM) is an important complementary and alternative
therapy for the management of irritable bowel syndrome (IBS). Previous meta-analyses …

[HTML][HTML] Systematic review and meta-analysis of Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: evidence for clinical …

SB Liang, HJ Cao, LY Kong, JL Wei… - Frontiers in …, 2022 - frontiersin.org
Introduction: Diarrhea-predominant irritable bowel syndrome (IBS-D) significantly decreases
the quality of life of patients and their families, and affects patients' mental health. No specific …

[HTML][HTML] Efficacy and safety of Qinghua Zhixie Decoction against diarrhea-predominate irritable bowel syndrome: A protocol for a randomized controlled trial

L Ji, X Zhao, Y Zhang, P Zhao, R Gong, F Li, H Huang - Medicine, 2022 - journals.lww.com
Background: Diarrhea-predominant irritable bowel syndrome (D-IBS) is the main subtypes of
irritable bowel syndrome (IBS). In recent years, more than half of IBS patients have received …

Exploration of the mechanism of Traditional Chinese Medicine for anxiety and depression in patients with diarrheal irritable bowel syndrome based on network …

C Bai, J Wang, Y Wang, H Liu, J Li, S Wang… - Frontiers in …, 2024 - frontiersin.org
Background The efficacy of Chinese herbal medicine (CHM) in managing irritable bowel
syndrome with diarrhea (IBS-D) accompanied by anxiety and depression remains uncertain …

[HTML][HTML] Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized, multiple-blind, placebo …

SB Liang, M Han, HJ Cheng, QY Zhang, NW Zhang… - Trials, 2022 - Springer
Introduction Diarrhea-predominant irritable bowel syndrome (IBS-D) is a bowel disease with
a high incidence. It significantly reduces the quality of life of patients and affects the patient's …